Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intramuscular use. It is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and short‑term treatment of moderate to severe pain where oral therapy is unsuitable, reducing inflammation and pain in adult patients.

GNH USA supplies Movalis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is manufactured under strict GMP conditions.

Movalis (meloxicam) is used in inflammatory joint diseases and acute pain conditions.

- Rheumatoid arthritis: reduces joint inflammation and pain, improving function. - Osteoarthritis: alleviates chronic joint discomfort and swelling. - Ankylosing spondylitis: diminishes spinal inflammation and stiffness. - Acute pain: provides short‑term relief of moderate to severe musculoskeletal pain.

Meloxicam may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache or dizziness. - Injection‑site pain or mild erythema. - Transient skin rash.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration. - Severe cardiovascular events such as myocardial infarction. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation or liver injury. - Acute renal impairment or failure. - Anaphylactic or severe hypersensitivity reactions.

Before prescribing Movalis, clinicians should consider several safety precautions to minimize risk.

- Gastro‑intestinal risk: assess history of ulcer disease or bleeding. - Cardiovascular risk: evaluate for existing heart disease or stroke. - Renal function: monitor creatinine and urine output in patients with kidney impairment. - Use the lowest effective dose for the shortest duration necessary. - Hypersensitivity: avoid in patients with known allergy to meloxicam or other NSAIDs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meloxicam can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): amplified bleeding tendency.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal perfusion. - ACE inhibitors or ARBs: may worsen renal function when combined.